Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01027416
What this trial is testing

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 59
Large-scale testing (Phase 3)UnknownNCT02801786
What this trial is testing

TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography

Who this might be right for
PainDiscomfort
Universidade Federal de Goias 450
Early research (Phase 1)Study completedNCT01971515
What this trial is testing

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
EMD Serono 101
Not applicableEnded earlyNCT05787457
What this trial is testing

Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland

Who this might be right for
Diabetes Mellitus, Type 2
Insel Gruppe AG, University Hospital Bern 34
Not applicableUnknownNCT00538330
What this trial is testing

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00040014
What this trial is testing

Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

Who this might be right for
Breast Neoplasms
Pfizer 100
Testing effectiveness (Phase 2)Study completedNCT01220076
What this trial is testing

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+

Who this might be right for
Non Metastatic Breast Cancer
Institut Cancerologie de l'Ouest 140
Testing effectiveness (Phase 2)Study completedNCT00068419
What this trial is testing

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Who this might be right for
Desmoid Tumor
Children's Oncology Group 70
Testing effectiveness (Phase 2)Study completedNCT03112031
What this trial is testing

Treatment With Tamoxifen in Cryptococcal Meningitis

Who this might be right for
Meningitis StreptococcalHivMeningitis+1 more
Oxford University Clinical Research Unit, Vietnam 50
Not applicableEnded earlyNCT05156606
What this trial is testing

Testosterone & Tamoxifen Trial

Who this might be right for
Male Breast Cancer
University Medical Center Groningen 5
Large-scale testing (Phase 3)Study completedNCT00754845
What this trial is testing

Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 1,918
Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Early research (Phase 1)Study completedNCT02835079
What this trial is testing

Treatment Effect of Tamoxifen on Patients With DMD

Who this might be right for
Duchenne Muscular Dystrophy
Hadassah Medical Organization 19
Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Testing effectiveness (Phase 2)Study completedNCT02668666
What this trial is testing

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEstrogen Receptor Positive Breast Cancer+2 more
Oana Danciu, MD 49
Large-scale testing (Phase 3)Study completedNCT02728622
What this trial is testing

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

Who this might be right for
Ovarian CancerPeritoneal CancerCancer of the Fallopian Tube
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 241
Large-scale testing (Phase 3)WithdrawnNCT00053339
What this trial is testing

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Who this might be right for
Stage IV Breast CancerRecurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Not applicableStudy completedNCT00005605
What this trial is testing

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Northwestern University 79
Large-scale testing (Phase 3)Study completedNCT00026286
What this trial is testing

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002542
What this trial is testing

Tamoxifen in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 672
Next Page